IL-10+ NK and TGF-β+ NK cells play negative regulatory roles in HIV infection

[1]  U. Dittmer,et al.  Insufficient natural killer cell responses against retroviruses: how to improve NK cell killing of retrovirus-infected cells , 2016, Retrovirology.

[2]  N. Cacalano.  Regulation of Natural Killer Cell Function by STAT3 , 2016, Front. Immunol..

[3]  R. Paranjape,et al.  HIV‐infected CD4+ T Cells Use T‐bet‐dependent Pathway for Production of IL‐10 Upon Antigen Recognition , 2016, Scandinavian journal of immunology.

[4]  David K. Finlay,et al.  TGF-β inhibits the activation and functions of NK cells by repressing the mTOR pathway , 2016, Science Signaling.

[5]  H. Kohrt,et al.  Natural Killer Cell Immunomodulation: Targeting Activating, Inhibitory, and Co-stimulatory Receptor Signaling for Cancer Immunotherapy , 2015, Front. Immunol..

[6]  G. Deniz,et al.  Peripheral blood NK cells expressing HLA-G, IL-10 and TGF-β in healthy donors and breast cancer patients. , 2015, Cellular immunology.

[7]  C. Hunter,et al.  The Aryl Hydrocarbon Receptor Promotes IL-10 Production by NK Cells , 2014, The Journal of Immunology.

[8]  Xiaoxu Han,et al.  Higher NK Cell IFN-γ Production is Associated with Delayed HIV Disease Progression in LTNPs , 2013, Journal of Clinical Immunology.

[9]  C. Ng,et al.  Infected CD8α− dendritic cells are the predominant source of IL-10 during establishment of persistent viral infection , 2012, Proceedings of the National Academy of Sciences.

[10]  R. Paranjape,et al.  Short communication: HIV antigen-specific reactivation of HIV infection from cellular reservoirs: implications in the settings of therapeutic vaccinations. , 2012, AIDS research and human retroviruses.

[11]  R. Konwar,et al.  Role of interleukin-10 in breast cancer , 2012, Breast Cancer Research and Treatment.

[12]  G. Hall,et al.  Human Tumour Immune Evasion via TGF-β Blocks NK Cell Activation but Not Survival Allowing Therapeutic Restoration of Anti-Tumour Activity , 2011, PloS one.

[13]  Haiyoung Jung,et al.  IL-15-induced IL-10 increases the cytolytic activity of human natural killer cells , 2011, Molecules and cells.

[14]  L. Lanier,et al.  TGF-beta downregulates the activating receptor NKG2D on NK cells and CD8+ T cells in glioma patients. , 2010, Neuro-oncology.

[15]  C. Karp,et al.  Systemic but not local infections elicit immunosuppressive IL-10 production by natural killer cells. , 2009, Cell host & microbe.

[16]  N. Jones,et al.  TGF-β and IL-10 Production by HIV-Specific CD8+ T Cells Is Regulated by CTLA-4 Signaling on CD4+ T Cells , 2009, PloS one.

[17]  Margarida Saraiva,et al.  Interleukin-10 Production by Th1 Cells Requires Interleukin-12-Induced STAT4 Transcription Factor and ERK MAP Kinase Activation by High Antigen Dose , 2009, Immunity.

[18]  H. Jessen,et al.  IL-10 is up-regulated in multiple cell types during viremic HIV infection and reversibly inhibits virus-specific T cells. , 2009, Blood.

[19]  N. Jones,et al.  TGF-\(\beta\) and IL-10 Production by HIV-Specific CD8+ T Cells Is Regulated by CTLA-4 Signaling on CD4+ T Cells , 2009 .

[20]  M. Caligiuri,et al.  TGF-β Utilizes SMAD3 to Inhibit CD16-Mediated IFN-γ Production and Antibody-Dependent Cellular Cytotoxicity in Human NK Cells1 , 2008, The Journal of Immunology.

[21]  M. Caligiuri,et al.  TGF-beta utilizes SMAD3 to inhibit CD16-mediated IFN-gamma production and antibody-dependent cellular cytotoxicity in human NK cells. , 2008, Journal of immunology.

[22]  Ashok Kumar,et al.  Intracellular HIV-Tat Expression Induces IL-10 Synthesis by the CREB-1 Transcription Factor through Ser133 Phosphorylation and Its Regulation by the ERK1/2 MAPK in Human Monocytic Cells* , 2006, Journal of Biological Chemistry.

[23]  L. Teyton,et al.  Interleukin-10 determines viral clearance or persistence in vivo , 2006, Nature Medicine.

[24]  L. Jing,et al.  Differential Expression of Perforin in Cytotoxic Lymphocyte in HIV/AIDS Patients of China , 2006, Journal of Clinical Immunology.

[25]  A. Poggi,et al.  HIV-1 Tat Triggers TGF-β Production and NK Cell Apoptosis that is Prevented by Pertussis Toxin B , 2006, Clinical & developmental immunology.

[26]  C. Akdis,et al.  Mechanisms of immune suppression by interleukin‐10 and transforming growth factor‐β: the role of T regulatory cells , 2006, Immunology.

[27]  F. Sutterwala,et al.  Transforming growth factor-β controls T helper type 1 cell development through regulation of natural killer cell interferon-γ , 2005, Nature Immunology.

[28]  F. Sutterwala,et al.  Transforming growth factor-beta controls T helper type 1 cell development through regulation of natural killer cell interferon-gamma. , 2005, Nature immunology.

[29]  Sarah K. Meadows,et al.  Unique phenotype of human uterine NK cells and their regulation by endogenous TGF‐β , 2004, Journal of leukocyte biology.

[30]  E. Bahraoui,et al.  HIV‐1 Tat protein induces interleukin‐10 in human peripheral blood monocytes: involvement of protein kinase C‐βII and ‐δ , 2002 .

[31]  E. Bahraoui,et al.  HIV-1 Tat protein induces interleukin-10 in human peripheral blood monocytes: involvement of protein kinase C-betaII and -delta. , 2002, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[32]  M. Caligiuri,et al.  The biology of human natural killer-cell subsets. , 2001, Trends in immunology.

[33]  M. Caligiuri,et al.  Human natural killer cells: a unique innate immunoregulatory role for the CD56bright subset , 2001 .

[34]  R. Coffman,et al.  Interleukin-10 and the interleukin-10 receptor. , 2001, Annual review of immunology.

[35]  T. Ghayur,et al.  Human natural killer cells: a unique innate immunoregulatory role for the CD56(bright) subset. , 2001, Blood.

[36]  M. Benkirane,et al.  Tat Protein of Human Immunodeficiency Virus Type 1 Induces Interleukin-10 in Human Peripheral Blood Monocytes: Implication of Protein Kinase C-Dependent Pathway , 2000, Journal of Virology.

[37]  S. Fidler,et al.  Antigen presenting cell function in HIV-1 infected patients. , 1999, Immunology letters.

[38]  M. Hirokawa,et al.  Generation of an inhibitory circuit involving CD8+ T cells, IL-2, and NK cell-derived TGF-beta: contrasting effects of anti-CD2 and anti-CD3. , 1998, Journal of immunology.

[39]  E. De Clercq,et al.  Human immunodeficiency virus type 1 gp120 induces anergy in human peripheral blood lymphocytes by inducing interleukin-10 production , 1996, Journal of virology.

[40]  S. Wahl,et al.  Transforming growth factor beta: the good, the bad, and the ugly , 1994, The Journal of experimental medicine.

[41]  J. Berzofsky,et al.  Role of interleukin-10 in T helper cell dysfunction in asymptomatic individuals infected with the human immunodeficiency virus. , 1994, The Journal of clinical investigation.

[42]  M. Sporn,et al.  Some recent advances in the chemistry and biology of transforming growth factor-beta , 1987, The Journal of cell biology.

[43]  G. Trinchieri,et al.  Human natural killer cells. , 1979, Transplantation proceedings.